دورية أكاديمية

1057PD - Final Results from a Cancer Research Uk First in Man Phase I Trial of Ima950 (A Novel Multi Peptide Vaccine) Plus Gm-Csf in Patients with Newly Diagnosed Glioblastoma

التفاصيل البيبلوغرافية
العنوان: 1057PD - Final Results from a Cancer Research Uk First in Man Phase I Trial of Ima950 (A Novel Multi Peptide Vaccine) Plus Gm-Csf in Patients with Newly Diagnosed Glioblastoma
المؤلفون: Halford, S., Rampling, R., James, A., Peoples, S., Mulholland, P., Al-Salihi, O., Twelves, C., McBain, C., Jefferies, S., Kutscher, S., Hilf, N., McGuigan, L., Peters, J., Roberts, K., Schoor, O., Ritchie, J., Singh-Jasuja, H.
المصدر: In Annals of Oncology September 2014 25 Supplement 4:iv364-iv364
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdu342.10